Therapeutic effects of rapamycin on MPTP-induced Parkinsonism in mice. - Wikidata - awgldk - TriplyDB

Therapeutic effects of rapamycin on MPTP-induced Parkinsonism in mice.

Therapeutic effects of rapamycin on MPTP-induced Parkinsonism in mice.

http://www.wikidata.org/entity/Q48311829

about

The role of autophagy in Parkinson's disease Protein degradation pathways in Parkinson's disease: curse or blessing Sulforaphane protects against rotenone-induced neurotoxicity in vivo: Involvement of the mTOR, Nrf2, and autophagy pathways.Potential therapeutic effects of the MTOR inhibitors for preventing ageing and progeria-related disorders Parkinson's disease as a result of aging How Parkinsonian toxins dysregulate the autophagy machinery Rapamycin improves motor function, reduces 4-hydroxynonenal adducted protein in brain, and attenuates synaptic injury in a mouse model of synucleinopathy Parkinson's disease-implicated kinases in the brain; insights into disease pathogenesis.The role of autophagic and lysosomal pathways in ischemic brain injury Roles of autophagy in MPP+-induced neurotoxicity in vivo: the involvement of mitochondria and α-synuclein aggregation Evidence for Immune Response, Axonal Dysfunction and Reduced Endocytosis in the Substantia Nigra in Early Stage Parkinson's Disease.Quantitative analysis of the therapeutic effect of magnolol on MPTP-induced mouse model of Parkinson's disease using in vivo 18F-9-fluoropropyl-(+)-dihydrotetrabenazine PET imaging.α-Synuclein oligomers and clinical implications for Parkinson disease.Treatment of geographic atrophy with subconjunctival sirolimus: results of a phase I/II clinical trial.Rapamycin Reduced Ischemic Brain Damage in Diabetic Animals Is Associated with Suppressions of mTOR and ERK1/2 Signaling.SLC35D3 increases autophagic activity in midbrain dopaminergic neurons by enhancing BECN1-ATG14-PIK3C3 complex formation.mTOR Inhibition: From Aging to Autism and Beyond.Toll-like receptor 2 is increased in neurons in Parkinson's disease brain and may contribute to alpha-synuclein pathology.Rapamycin modulated brain-derived neurotrophic factor and B-cell lymphoma 2 to mitigate autism spectrum disorder in rats.Neuronal hemoglobin affects dopaminergic cells' response to stress Rapamycin upregulates glutamate transporter and IL-6 expression in astrocytes in a mouse model of Parkinson's disease.Mitophagy in ischaemia/reperfusion induced cerebral injury.Aberrant autophagy and parkinsonism: does correction rescue from disease progression?Defective autophagy in Parkinson's disease: lessons from genetics.Recent advances in autophagy-based neuroprotection.Carnosic Acid Attenuates 6-Hydroxydopamine-Induced Neurotoxicity in SH-SY5Y Cells by Inducing Autophagy Through an Enhanced Interaction of Parkin and Beclin1.Protein-protein interaction networks identify targets which rescue the MPP+ cellular model of Parkinson's disease.Investigational α-synuclein aggregation inhibitors: hope for Parkinson's disease.Autophagy in acute brain injury.Salsolinol Damaged Neuroblastoma SH-SY5Y Cells Induce Proliferation of Human Monocyte THP-1 Cells Through the mTOR Pathway in a Co-culture System.Autophagy regulates MAVS signaling activation in a phosphorylation-dependent manner in microglia.Pharmacological modulation of autophagy: therapeutic potential and persisting obstacles.Mitophagy in Parkinson's Disease: Pathogenic and Therapeutic Implications.Dynamic expressions of Beclin 1 and tyrosine hydroxylase in different areas of 6-hydroxydopamine-induced Parkinsonian rats.Neurotoxin mechanisms and processes relevant to Parkinson's disease: an update.An adverse outcome pathway for parkinsonian motor deficits associated with mitochondrial complex I inhibition.Neuroprotective strategies to prevent and treat Parkinson's disease based on its pathophysiological mechanism.Deciphering the pathways that protect from IL-13-mediated potentiation of oxidative stress-induced dopaminergic nerve cell death.Linking Glycation and Glycosylation With Inflammation and Mitochondrial Dysfunction in Parkinson’s Disease.

P2860

Q27023788-4844DE1B-93B1-48F5-BAF0-3A769D247BB3 Q27026029-5D55CD8E-65EE-4078-AFD8-2C06B018E9F5 Q27314642-7DCD1952-292D-41E4-8A9C-32A291F612E9 Q28067037-AD3081F2-FA02-4D7A-9DFA-03DD094507C8 Q28084395-451AEEC6-AE33-4CE4-935E-70F2F09EEE95 Q28392567-062C0715-091D-4EB2-A8C9-F1500C9B21E4 Q30662442-41F8CEFE-6BF5-4339-A12E-5F785C175A25 Q33797449-1451ADE0-F795-4D20-9625-667DAF73F4C1 Q34095506-C5A67D12-A244-4697-AD5D-14DFB70B76AD Q35124948-0C894CD4-DE0A-451C-A128-AFE41BC25A0F Q35667600-062906B7-989C-47C5-90D2-88641FD7A0F4 Q36296658-C25D0D6D-0C1E-4E7A-9E6A-55F3BF81DCA7 Q36718306-57D2D23D-7AD2-4D60-B943-D671263D4398 Q36801990-0A959223-CA0F-48EB-BD10-97FF17B70DC0 Q37148571-98725419-93C1-4F35-B7F1-E2CF4DFE3AD2 Q37189119-A4D38949-1BAB-4A51-B271-00D2D4463066 Q37385781-9C6203C5-C34C-4293-95FE-351494C29462 Q37596779-FC539763-7699-4B7D-A2A5-5A31D61324D0 Q37720699-9CF23E1B-1BFD-4553-B4F9-9E03A1D23850 Q37744906-70FC7B6B-2877-4D24-B4AB-C8124B4BEC7B Q37745148-ED9950C5-B70B-4052-885C-3E5D18EB71AB Q38096954-D4B7D6DC-1BA6-443A-A1BF-1E4E014C557C Q38212199-A6407D84-6398-46C1-8081-67CF522AFA67 Q38225786-F6019E29-3530-4E06-83DF-3790DF138001 Q38329808-B4C33305-74C8-41E0-B6A7-A9C0F91982BD Q38783226-65905FCE-55AE-4DAB-9AC1-F85435B5801A Q38816615-94C7E350-5D88-4B91-8D22-9ECA063F65A7 Q38817063-C01BADB6-E29B-4767-A849-DBBDB848793A Q38852246-21075ADC-9090-4E51-9CAA-252430703538 Q38899693-4D1F2E17-91C4-463E-BBFC-59729AB39EAB Q38988911-67A1EEBF-D4F3-488A-A088-BB5AF2248C37 Q39321120-42E68733-7858-458E-A748-3129B7372422 Q42372932-D9129309-1A78-4604-BDBD-7391495A31CA Q43436198-57F61E4D-0B66-437F-9DF9-7A1D92CA6747 Q43679571-61C8817A-33E3-485A-BFA6-50F6B30316EA Q48171351-B7B44C12-ACFB-46EF-8941-264DF490F354 Q49797218-0A258107-06DE-425F-BC6D-26460498FC7D Q53776575-F4ECDED5-D415-442F-819D-97EDCB5F4243 Q55226753-511AD0D1-17C8-429A-B824-27726E88C1F4

P2860

Therapeutic effects of rapamycin on MPTP-induced Parkinsonism in mice.

http://www.wikidata.org/entity/Q48311829

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh-hant

name

Therapeutic effects of rapamycin on MPTP-induced Parkinsonism in mice.

@en

Therapeutic effects of rapamycin on MPTP-induced Parkinsonism in mice.

@nl

type

label

Therapeutic effects of rapamycin on MPTP-induced Parkinsonism in mice.

@en

Therapeutic effects of rapamycin on MPTP-induced Parkinsonism in mice.

@nl

prefLabel

Therapeutic effects of rapamycin on MPTP-induced Parkinsonism in mice.

@en

Therapeutic effects of rapamycin on MPTP-induced Parkinsonism in mice.

@nl

P1433

Q48311829-D0012C6B-FB15-4AE8-A69A-4FDEBDAEBE6D

P1476

Q48311829-302C2C54-575E-45AD-9CED-9B27C9E5706B

P2093

Q48311829-1CA852A1-6113-44DC-BCE4-E62C9CDEBAAF

Q48311829-36866EC4-494B-41CA-9570-4BA346678795

Q48311829-5B1C3635-9D87-4A3D-9F24-07A2BE8CDA79

Q48311829-6FB7B72F-CC7A-4CA3-9EAF-A96D9A7825D8

Q48311829-E0A847B2-BDE2-41EE-A7A8-4992AC8846B1

P2860

Q48311829-03D737A7-50E7-45EF-931B-54A44C5D7F1A

Q48311829-04F2355A-CF5D-49E6-9CA3-D0C7DCEF4875

Q48311829-06328F83-71E2-4C53-BDF1-B7997DB966C3

Q48311829-157CE8C9-E409-45F5-947A-CCA1DEAE9273

Q48311829-1AEEF26F-482D-40F6-94AF-410262C18993

Q48311829-2D165B6D-CDB7-4A0C-8712-6EAAA600EABD

Q48311829-30CF49A8-A38C-4A5F-AB01-E3EBE0CB7749

Q48311829-35E7DD7C-C17D-4DE1-B2A1-E7DD13312814

Q48311829-440C1193-23D8-411B-A4D9-D2B27BA1795F

Q48311829-52A7B4EB-FCF0-4CE6-8F86-5D256E977D13

P2888

Q48311829-6214E631-2009-46C9-AB10-B373218AC3C0

P304

Q48311829-FEBEC347-AB33-4F5F-87AB-C97836251DF8

P31

Q48311829-D6D7E907-D37F-4A52-87B4-6417C778D473

P356

Q48311829-8369FDB3-B34E-4FC6-8946-EF463F5391FD

P433

Q48311829-5E147B29-A924-47D1-9FC2-862B55F7AD22

P478

Q48311829-EC0CC36A-8290-417C-8894-192DE8303343

P577

Q48311829-36EB7E9B-DB37-435C-A8EA-F8FBD2885D92

P698

Q48311829-04C0A827-5337-4592-825E-3C3BD567D68E

P921

Q48311829-4175BD53-31A8-484A-9A8F-106BBC8EBF51

P356

S11064-012-0909-8

P1433

Neurochemical Research

P1476

Therapeutic effects of rapamycin on MPTP-induced Parkinsonism in mice.

@en

P2093

Kangyong Liu

http://www.w3.org/2001/XMLSchema#string

Nan Shi

http://www.w3.org/2001/XMLSchema#string

Ting Zhang

http://www.w3.org/2001/XMLSchema#string

Xiaojiang Sun

http://www.w3.org/2001/XMLSchema#string

Yinyi Sun

http://www.w3.org/2001/XMLSchema#string

P2860

A new protein conjugation system in human. The counterpart of the yeast Apg12p conjugation system essential for autophagy

Tor-mediated induction of autophagy via an Apg1 protein kinase complex

Alpha-synuclein in Lewy bodies

The roles of intracellular protein-degradation pathways in neurodegeneration

RTP801 is induced in Parkinson's disease and mediates neuron death by inhibiting Akt phosphorylation/activation

Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease

Regulation mechanisms and signaling pathways of autophagy

Development by self-digestion: molecular mechanisms and biological functions of autophagy

Autophagy as a regulated pathway of cellular degradation

Epidemiology of Parkinson's disease

P2888

s11064-012-0909-8

P304

201-207

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11064-012-0909-8

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

38

http://www.w3.org/2001/XMLSchema#string

P577

2012-11-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23117422

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease